What development phase is Levamphetamine in?

Levamphetamine is FDA-approved (marketed).

What is the generic name of Levamphetamine?

LEVAMFETAMINE is the generic (nonproprietary) name of Levamphetamine.

Last reviewed 2026-04-20 · How we verify

Levamphetamine (LEVAMFETAMINE)

FDA-approved withdrawn Small molecule Quality 21/100

At a glance

Generic name	LEVAMFETAMINE
Drug class	levamfetamine
Target	Sigma non-opioid intracellular receptor 1, Trace amine-associated receptor 1, Serotonin (5-HT) receptor
Modality	Small molecule
Therapeutic area	Pain
Phase	FDA-approved
Annual revenue	172

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
SEC EDGAR	Revenue + earnings

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Levamphetamine CI brief — competitive landscape report
Levamphetamine updates RSS · CI watch RSS